Alena Opattova

Prague, PR 10000, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

WEE1 kinase inhibition to overcome acquired resistance to targeted therapies in colorectal cancer.

WEE1 kinase inhibition to overcome acquired resistance to targeted therapies in colorectal cancer.

Journal: EMBO molecular medicine

Published: September 30, 2025

Novel frontiers in urogenital cancers: from molecular bases to preclinical models to tailor personalized treatments in ovarian and prostate cancer patients.

Novel frontiers in urogenital cancers: from molecular bases to preclinical models to tailor personalized treatments in ovarian and prostate cancer patients.

Journal: Journal of experimental & clinical cancer research : CR

Published: January 31, 2024

Inhibition of homologous recombination repair by Mirin in ovarian cancer ameliorates carboplatin therapy response in vitro.

Inhibition of homologous recombination repair by Mirin in ovarian cancer ameliorates carboplatin therapy response in vitro.

Journal: Mutagenesis

Published: September 11, 2023

MUC13-miRNA-4647 axis in colorectal cancer: Prospects to identifications of risk factors and clinical outcomes.

MUC13-miRNA-4647 axis in colorectal cancer: Prospects to identifications of risk factors and clinical outcomes.

Journal: Oncology letters

Published: August 04, 2022

An investigation of DNA damage and DNA repair in chemical carcinogenesis triggered by small-molecule xenobiotics and in cancer: Thirty years with the comet assay.

An investigation of DNA damage and DNA repair in chemical carcinogenesis triggered by small-molecule xenobiotics and in cancer: Thirty years with the comet assay.

Journal: Mutation research. Genetic toxicology and environmental mutagenesis

Published: July 29, 2022

MiR-140 leads to MRE11 downregulation and ameliorates oxaliplatin treatment and therapy response in colorectal cancer patients.

MiR-140 leads to MRE11 downregulation and ameliorates oxaliplatin treatment and therapy response in colorectal cancer patients.

Journal: Frontiers in oncology

Published: June 01, 2022

Oxidative Damage in Sporadic Colorectal Cancer: Molecular Mapping of Base Excision Repair Glycosylases MUTYH and hOGG1 in Colorectal Cancer Patients.

Oxidative Damage in Sporadic Colorectal Cancer: Molecular Mapping of Base Excision Repair Glycosylases MUTYH and hOGG1 in Colorectal Cancer Patients.

Journal: International journal of molecular sciences

Published: April 14, 2022

A pooled analysis of molecular epidemiological studies on modulation of DNA repair by host factors.

A pooled analysis of molecular epidemiological studies on modulation of DNA repair by host factors.

Journal: Mutation research. Genetic toxicology and environmental mutagenesis

Published: May 28, 2021

Analysis of MicroRNA Expression Changes During the Course of Therapy In Rectal Cancer Patients.

Analysis of MicroRNA Expression Changes During the Course of Therapy In Rectal Cancer Patients.

Journal: Frontiers in oncology

Published: April 29, 2021

The Interactions of DNA Repair, Telomere Homeostasis, and p53 Mutational Status in Solid Cancers: Risk, Prognosis, and Prediction.

The Interactions of DNA Repair, Telomere Homeostasis, and p53 Mutational Status in Solid Cancers: Risk, Prognosis, and Prediction.

Journal: Cancers

Published: December 06, 2020

Genetic variations in 3'UTRs of SMUG1 and NEIL2 genes modulate breast cancer risk, survival and therapy response.

Genetic variations in 3'UTRs of SMUG1 and NEIL2 genes modulate breast cancer risk, survival and therapy response.

Journal: Mutagenesis

Published: December 01, 2020

An optimized comet-based in vitro DNA repair assay to assess base and nucleotide excision repair activity.

An optimized comet-based in vitro DNA repair assay to assess base and nucleotide excision repair activity.

Journal: Nature protocols

Published: March 16, 2020

Showing 1-12 of 20

Last Updated: 09/26/2026